Dr Throwers Oily Skin Facial Astringent

Description

The product is identified by the SPL code 34089-3. No additional specific description details are provided in the available data.

Uses and Indications

This drug is indicated for the topical treatment of affected skin areas. It is essential to clean the skin thoroughly before application. The product should be applied using a cotton ball to cover the entire affected area with a thin layer one to three times daily, as directed. Care should be taken to avoid the eye area, corners of the nose, and around the mouth.

Due to the potential for excessive drying of the skin, it is recommended to start with one application daily. The frequency may be gradually increased to two or three times daily if necessary or as directed by a healthcare professional. In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once a day or every other day.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The formulation is designed to dry and clear acne blemishes while facilitating the healing of the skin. Healthcare professionals should instruct patients on the appropriate application technique to ensure optimal results.

Patients are advised to apply the product directly to the affected areas of the skin. It is important to monitor the skin's response to the treatment and adjust the frequency of application as necessary, based on individual tolerance and the severity of the acne. Regular follow-up may be beneficial to assess the effectiveness of the treatment and make any necessary adjustments.

Contraindications

There are no specific contraindications listed for this product. However, it is advised that if the product is swallowed, immediate medical assistance should be sought or contact with a Poison Control Center should be made.

Warnings and Precautions

The product is intended for external use only. It is important to note that the formulation is flammable; therefore, it should be kept away from open fire or flame to prevent any risk of ignition.

Healthcare professionals should be aware that the concurrent use of this product with other topical acne medications may increase the likelihood of skin irritation and dryness. In cases where irritation occurs, it is advisable to limit the use to one topical acne medication at a time to mitigate adverse effects.

In the event of accidental ingestion, immediate medical assistance should be sought. It is recommended to contact a Poison Control Center without delay to ensure appropriate management.

Patients should be instructed to discontinue use and consult their healthcare provider if they experience any concerning symptoms, although specific instructions for cessation were not provided in the available information.

Side Effects

Patients using this product should be aware that it is for external use only and is flammable; therefore, it should be kept away from open fire or flame.

In clinical practice, skin irritation and dryness have been reported as common adverse reactions, particularly when this product is used concurrently with other topical acne medications. To minimize the risk of irritation, it is advised that patients use only one topical acne medication at a time. If irritation occurs, discontinuation of the product may be necessary.

Drug Interactions

The concurrent use of this product with other topical acne medications may increase the risk of skin irritation and dryness. To mitigate these effects, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the products should be considered to alleviate symptoms. Monitoring for signs of skin irritation is recommended during the use of this product in conjunction with other topical treatments.

Packaging & NDC

Below are the non-prescription pack sizes of Dr Throwers Oily Skin Facial Astringent (salicylic acid 2%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this medication. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For topical application, it is recommended to initiate treatment with one application daily. Depending on the patient's response and under the guidance of a healthcare professional, the frequency may be gradually increased to two or three times daily. Care should be taken to observe for signs of excessive drying of the skin. If bothersome dryness or peeling occurs, the application frequency should be reduced to once a day or every other day.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should be aware that the safety of this medication during pregnancy has not been specifically established. There are no available data regarding potential risks or fetal outcomes associated with the use of this medication in pregnant individuals. Healthcare professionals are advised to consider the potential benefits and risks when prescribing this medication to women of childbearing potential. It is recommended that healthcare providers discuss any concerns with their patients and consider alternative treatment options if necessary.

Lactation

There are no specific warnings or recommendations regarding nursing mothers. Additionally, there are no specific considerations or precautions related to lactation. Therefore, healthcare professionals may not need to take special precautions when prescribing this medication to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and intervention strategies.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that in the event of accidental ingestion, it is crucial to seek medical assistance immediately or contact a Poison Control Center. This prompt action is essential to ensure the safety and well-being of the patient.

Storage and Handling

This product is supplied in a plastic bottle. It is essential to keep the product away from open fire or flame due to its flammable nature. Additionally, it should be stored in a location that is out of reach of children to ensure safety.

Additional Clinical Information

The route of administration for the medication is topical. Clinicians should advise patients that if irritation occurs, they should limit the use to one topical acne medication at a time. In cases of bothersome dryness or peeling, patients are recommended to reduce the application frequency to once a day or every other day.

Drug Information (PDF)

This file contains official product information for Dr Throwers Oily Skin Facial Astringent, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)